Exon skipping of TGFβRI affects signalling and ECM expression in hypertrophic scar-derived fibroblasts.
Rajiv S RaktoeMarion H RietveldJacoba J Out-LuitingMarianna Kruithof-de JulioPaul Pm van ZuijlenRemco van DoornAbdoelwaheb El GhalbzouriPublished in: Scars, burns & healing (2020)
Exon skipping is a promising tool to modulate the TGF-β signalling pathway in HS. This would open a therapeutic window for the treatment of patients suffering from HSs.